ABOUT US
VISION
The R&D vision of Innophore is to identify high-value industrial and therapeutic enzymes and to develop and identify enzymes for more efficient, green chemical production processes and novel biosimilars for medical treatments.
Furthermore, we strive to make important contributions to the re-purposing of drugs as well as the prediction of drug side effects with the help of our 3D point cloud technology.


TEAM

Dr. Christian Gruber
CEO

Dr. Georg Steinkellner
CTO

Prof. Karl Gruber
CSO

Christoph Blaschitz, MSc.
CFO

Dr. Mario Müller
Research Manager and coordinator

Dr. Vedat Durmaz
Senior Data Scientist

PD Dr. Andreas Krassnigg
Senior AI Strategist/Developer

Dr. Marco Cespugli
Structural Bioinformatician

PD Dr. Bettina Nestl
Senior Scientist / Key Account Management

Ursula Kahler, MSc.
Scientist

Alexander Korsunsky, MSc.
Scientific Software Developer

Michael Hetmann, MSc
Structural Bioinformatician

Amela Kurtić, BSc.
Full-Stack Developer

Daniel Nutz
Data Scientist

Klara Blaschitz
Researcher

Katharina Köchl, Bsc
Master Student

Centina König
Programmer

Mag. Sabrina Krammer, MBA
Funding

Mag. Hanna Lindermuth
Technical writing and grant coordination support

Alice Guarneri, MSc
PhD Student, ESR/PBC
Innophore GmbH is a spin-off company of acib GmbH and University of Graz and was supported as founding project by Science Park Graz GmbH in the framework of the AplusB program.
Innophore GmbH is supported by the strategic investor EOSS Industries GmbH.